Drugs / polyvalent melanoma vaccine
last change Jul 2000 re-read 2 minutes ago

polyvalent melanoma vaccine

Vaccine

Developed for
cutaneous melanoma
Investigated by
NYU Langone Health · National Cancer Institute (NCI)

Trials 1 · a red edge is where a trial was stopped

199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00004104 Jun 1998 → Jul 2000 cutaneous melanoma NYU Langone Health Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as polyvalent melanoma vaccine ClinicalTrials.gov intervention name — accepted as the source's own label NCT00004104
Modality Vaccine “polyvalent melanoma vaccineNCT00004104